Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status

Por Lee, Jeeyun, Jain, Anjali, Kim, Phillip, Lee, Tani, Kuller, Anne, Princen, Fred, In-Gu, Kim, Suk Hyeong, Park, Joon Oh, Park, Young Suk, Singh, Sharat, Kim, Hee Cheol
Publicado em 2014

Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan

Por Kim, Seung Tae, Ahn, Tae Jin, Lee, Eunjin, Do, In-Gu, Lee, Su Jin, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Kim, Suk Hyeong, Lee, Jeeyun, Kim, Hee Cheol
Publicado no BMC Cancer (2015)